Erin Parsons

CIK: 0001895795

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)0 (0.0%)

Position reduction

Option Exercises (M)0 (0.0%)

Derivative conversions

Awards (A)2 (40.0%)

Compensation grants

Other (G, F, J, C, D, …)3 (60.0%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (2)

KPRX

KIORA PHARMACEUTICALS INC

Director

ALIM

ALIMERA SCIENCES INC

Director

Discretionary Trading P&L

Holdings

Transaction History (5 total)

KPRX
KIORA PHARMACEUTICALS INC
Jun 10, 2026
Award(A)
Stock Option (right to buy)
Direct
25K shares-
KPRX
KIORA PHARMACEUTICALS INC
Apr 1, 2025
Award(A)
Stock Option (right to buy)
Direct
20K shares-
ALIM
ALIMERA SCIENCES INC
Sep 16, 2024
Disposition(D)
Stock Option (Right to Buy)
Direct
50K shares-
ALIM
ALIMERA SCIENCES INC
Sep 16, 2024
Disposition(D)
Stock Option (Right to Buy)
Direct
6K shares-
ALIM
ALIMERA SCIENCES INC
Sep 16, 2024
Disposition(D)
Stock Option (Right to Buy)
Direct
3.3K shares-

		Type	Shares	Price		Ownership
Jun 10, 2026	KPRX KIORA PHARMACEUTICALS INC	Award(A) Stock Option (right to buy)	25,000	-	-	Direct
Apr 1, 2025	KPRX KIORA PHARMACEUTICALS INC	Award(A) Stock Option (right to buy)	20,000	-	-	Direct
Sep 16, 2024	ALIM ALIMERA SCIENCES INC	Disposition(D) Stock Option (Right to Buy)	50,000	-	-	Direct
Sep 16, 2024	ALIM ALIMERA SCIENCES INC	Disposition(D) Stock Option (Right to Buy)	6,000	-	-	Direct
Sep 16, 2024	ALIM ALIMERA SCIENCES INC	Disposition(D) Stock Option (Right to Buy)	3,255	-	-	Direct

1-5 of 5 transactions

About Parsons Erin

Parsons Erin (SEC CIK 0001895795) files insider reports with the SEC as Director of KIORA PHARMACEUTICALS INC (KPRX) and Director of ALIMERA SCIENCES INC (ALIM).

Signal8 holds 3 ownership filings by Parsons Erin, all Form 4s, filed between Sep 18, 2024 and Jun 12, 2026. Those filings report 5 transactions, from Sep 16, 2024 to Jun 10, 2026. Signal8's Form 4 history starts in Sep 2024.

The business address on Parsons Erin's filings is in ENCINITAS, CA.

Recent filings by Parsons Erin

Jun 10, 2026: Grant or award of KPRX derivative securities (Form 4, code A).
Apr 1, 2025: Grant or award of KPRX derivative securities (Form 4, code A).
Sep 16, 2024: Disposition to issuer transactions of ALIM derivative securities (3 lines, Form 4, code D).

Other insiders filing for KIORA PHARMACEUTICALS INC (KPRX)

Lane Keith J., Officer
Tosca Melissa, CFO
Strem Brian M., President and CEO
Stengone Carmine N., Director
Shapiro Aron, Director
Hollander David, Director

How to read Form 4 transaction codes